Global Personalized Cancer Medicine Market Growth (Status and Outlook) 2024-2030

2024

Global Personalized Cancer Medicine Market Growth (Status and Outlook) 2024-2030

Name: Global Personalized Cancer Medicine Market Growth (Status and Outlook) 2024-2030
Creator: Bonafide Research
License: https://www.bonafideresearch.com/license_information

Personalized Cancer Medicine, valued at US$ 158.18 billion in 2023, is expected to reach US$ 371.13 billion by 2030, with a 13.0% CAGR driven by growing demand in the downstream ma

Bonafide Trust
04-01-2024
Pages : 146
Figures : 83
Tables : 150
Region : Global
Category : Lifescience
Pharmaceutical

Buy Now Get Free sample

Request new version

Request for updated version of the report at the same price

Order Now

According to Publisher’s latest study, the global Personalized Cancer Medicine market size was valued at US$ 158180 million in 2023. With the growing demand in the downstream market, Personalized Cancer Medicine is forecast to a readjusted size of US$ 371130 million by 2030 with a CAGR of 13.0% during the review period.
The research report highlights the growth potential of the global Personalized Cancer Medicine market. Personalized Cancer Medicine is expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Personalized Cancer Medicine. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Personalized Cancer Medicine market.
Personalized cancer medicine, also known as targeted therapies or precision medicines, are medications designed to specifically target the unique genetic or molecular characteristics of an individual patient's cancer. These drugs are a central component of personalized cancer medicine and are chosen based on the genomic and molecular profiling of the patient's tumor.
Immunotherapies: While not traditional targeted therapies, immunotherapies like immune checkpoint inhibitors are another form of personalized cancer treatment. These drugs enhance the patient's immune system to recognize and attack cancer cells, and they can be tailored to patients based on their tumor's molecular characteristics.
Personalized cancer treatment drugs have revolutionized cancer care by allowing oncologists to tailor treatment plans to the individual characteristics of each patient's cancer. This approach holds great promise for improving outcomes and reducing the side effects associated with traditional cancer treatments. However, ongoing research and advancements are needed to expand the repertoire of targeted therapies and ensure that they are accessible to more cancer patients.
In the global market, the core manufacturers of Precision Cancer Medicine (Personalised Cancer Medicine) are AbbVie, Johnson & Johnson, Novartis, and others. The top three players within this industry account for about 30% of the market share. North America, Europe, and Asia Pacific are the major manufacturing regions for this product, with North America accounting for over 50% of the global market share. The product can be classified based on treatment into immunotherapy and targeted therapy drugs. The product is widely used in the treatment of lung, breast, prostate, blood and other cancers.

Key Features:
The report on the Personalized Cancer Medicine market reflects various aspects and provides valuable insights into the industry.
Market Size and Growth: The research report provides an overview of the current size and growth of the Personalized Cancer Medicine market. It may include historical data, market segmentation by Method (e.g., Cancer Immunotherapy, Targeted Therapy), and regional breakdowns.

What's Inside a Bonafide Research`s industry report?

A Bonafide Research industry report provides in-depth market analysis, trends, competitive insights, and strategic recommendations to help businesses make informed decisions.

Download Sample

Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Personalized Cancer Medicine market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides an analysis of the competitive landscape within the Personalized Cancer Medicine market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Personalized Cancer Medicine industry. This includes advancements in Personalized Cancer Medicine technology, Personalized Cancer Medicine new entrants, Personalized Cancer Medicine new investments, and other innovations that are shaping the future of Personalized Cancer Medicine.
The FDA approved Freenome (Netherlands)'s ColonSentry blood test, a non-invasive method of detecting colorectal cancer. A comprehensive liquid biopsy test called Guardant360 CDx, developed by Guardant Health (US), can detect several cancer forms from a single blood sample. The US-based Foundation Medicine and the Swiss company Roche are working together to provide next-generation companion diagnostics for targeted cancer treatments. These tests will assist physicians in customizing care regimens according to the unique genetic composition of each patient.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Personalized Cancer Medicine market. It includes factors influencing customers' purchasing decisions, and preferences for Personalized Cancer Medicine products.
Government Policies and Incentives: The research report analyses the impact of government policies and incentives on the Personalized Cancer Medicine market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting the Personalized Cancer Medicine market. The report also evaluates the effectiveness of these policies in driving market growth.

Environmental Impact and Sustainability: The research report assesses the environmental impact and sustainability aspects of the Personalized Cancer Medicine market.

Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provides market forecasts and outlook for the Personalized Cancer Medicine industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report concludes with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Personalized Cancer Medicine market.

Make this report your own

Have queries/questions regarding a report

Take advantage of intelligence tailored to your business objective

Manmayi Raval

Research Consultant

Market Segmentation:
The Personalized Cancer Medicine market is split by Method and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Method, and by Application in terms of value.
1. Segmentation by method
i) Cancer Immunotherapy
ii) Targeted Therapy
2. Segmentation by application
i) Lung Cancer
ii) Breast Cancer
iii) Prostate Cancer
iv) Blood-related Cancer
v) Other
This report also splits the market by region: The markets for customized medications in America, Europe, Asia-Pacific, and the Middle East & Africa are examined. Due to the presence of several major players, the American market for personalized cancer medicines accounted for a significant portion of the global market and is expected to continue to dominate the rest of the forecast period. The high rate of cancer in America is also driving up demand for personalized medicine solutions that offer more focused and efficient treatment regimens.
Throughout the projection period, Asia-Pacific is anticipated to increase at the fastest rate. The presence of pharmaceutical businesses in the area and the rise in the purchasing power of populous nations like China and India are responsible for the market's expansion. Additionally, it is projected that the market will develop due to an increase in the cost of personalized medicine and the use of high-tech processing to enhance the creation of personalized solutions.
In addition, the population of the Asia-Pacific area is expanding, creating a demand for more individualized healthcare options, such as tailored cancer treatments. In addition, the Asia-Pacific region's ageing population and rising cancer incidence are fuelling the need for more precise and potent treatments. Here, new personalized medicine solutions are being developed and made possible by technological advancements in genomics, bioinformatics, and other fields.
1) Americas
i) United States
ii) Canada
iii) Mexico
iv) Brazil
2) APAC
i) China
ii) Japan
iii) Korea
iv) Southeast Asia
v) India
vi) Australia
3) Europe
i) Germany
ii) France
iii) UK
iv) Italy
v) Russia
4) Middle East & Africa
i) Egypt
ii) South Africa
iii) Israel
iv) Turkey
v) GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
• AbbVie
• Johnson & Johnson
• Novartis
• Gilead Sciences
• Roche
• Bristol-Myers Squibb
• Amgen
• AstraZeneca
• Merck & Co
• Takeda
• Merck KGaA
• Seagen
• Eli Lilly
• Ono Pharmaceutical
• Pfizer
• GSK
• Exelixis
• Regeneron
• Innovent
• Hengrui Medicine

Don’t pay for what you don’t need. Save 30%

Customise your report by selecting specific countries or regions

Specify Scope Now

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Personalized Cancer Medicine Market Size 2019-2030
2.1.2 Personalized Cancer Medicine Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Personalized Cancer Medicine Segment by Method
2.2.1 Cancer Immunotherapy
2.2.2 Targeted Therapy
2.3 Personalized Cancer Medicine Market Size by Method
2.3.1 Personalized Cancer Medicine Market Size CAGR by Method (2019 VS 2023 VS 2030)
2.3.2 Global Personalized Cancer Medicine Market Size Market Share by Method (2019-2024)
2.4 Personalized Cancer Medicine Segment by Application
2.4.1 Lung Cancer
2.4.2 Breast Cancer
2.4.3 Prostate Cancer
2.4.4 Blood-related Cancer
2.4.5 Other
2.5 Personalized Cancer Medicine Market Size by Application
2.5.1 Personalized Cancer Medicine Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Personalized Cancer Medicine Market Size Market Share by Application (2019-2024)
3 Personalized Cancer Medicine Market Size by Player
3.1 Personalized Cancer Medicine Market Size Market Share by Players
3.1.1 Global Personalized Cancer Medicine Revenue by Players (2019-2024)
3.1.2 Global Personalized Cancer Medicine Revenue Market Share by Players (2019-2024)
3.2 Global Personalized Cancer Medicine Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Personalized Cancer Medicine by Regions
4.1 Personalized Cancer Medicine Market Size by Regions (2019-2024)
4.2 Americas Personalized Cancer Medicine Market Size Growth (2019-2024)
4.3 APAC Personalized Cancer Medicine Market Size Growth (2019-2024)
4.4 Europe Personalized Cancer Medicine Market Size Growth (2019-2024)
4.5 Middle East & Africa Personalized Cancer Medicine Market Size Growth (2019-2024)
5 Americas
5.1 Americas Personalized Cancer Medicine Market Size by Country (2019-2024)
5.2 Americas Personalized Cancer Medicine Market Size by Method (2019-2024)
5.3 Americas Personalized Cancer Medicine Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Personalized Cancer Medicine Market Size by Region (2019-2024)
6.2 APAC Personalized Cancer Medicine Market Size by Method (2019-2024)
6.3 APAC Personalized Cancer Medicine Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Personalized Cancer Medicine by Country (2019-2024)
7.2 Europe Personalized Cancer Medicine Market Size by Method (2019-2024)
7.3 Europe Personalized Cancer Medicine Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Personalized Cancer Medicine by Region (2019-2024)
8.2 Middle East & Africa Personalized Cancer Medicine Market Size by Method (2019-2024)
8.3 Middle East & Africa Personalized Cancer Medicine Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Personalized Cancer Medicine Market Forecast
10.1 Global Personalized Cancer Medicine Forecast by Regions (2025-2030)
10.1.1 Global Personalized Cancer Medicine Forecast by Regions (2025-2030)
10.1.2 Americas Personalized Cancer Medicine Forecast
10.1.3 APAC Personalized Cancer Medicine Forecast
10.1.4 Europe Personalized Cancer Medicine Forecast
10.1.5 Middle East & Africa Personalized Cancer Medicine Forecast
10.2 Americas Personalized Cancer Medicine Forecast by Country (2025-2030)
10.2.1 United States Personalized Cancer Medicine Market Forecast
10.2.2 Canada Personalized Cancer Medicine Market Forecast
10.2.3 Mexico Personalized Cancer Medicine Market Forecast
10.2.4 Brazil Personalized Cancer Medicine Market Forecast
10.3 APAC Personalized Cancer Medicine Forecast by Region (2025-2030)
10.3.1 China Personalized Cancer Medicine Market Forecast
10.3.2 Japan Personalized Cancer Medicine Market Forecast
10.3.3 Korea Personalized Cancer Medicine Market Forecast
10.3.4 Southeast Asia Personalized Cancer Medicine Market Forecast
10.3.5 India Personalized Cancer Medicine Market Forecast
10.3.6 Australia Personalized Cancer Medicine Market Forecast
10.4 Europe Personalized Cancer Medicine Forecast by Country (2025-2030)
10.4.1 Germany Personalized Cancer Medicine Market Forecast
10.4.2 France Personalized Cancer Medicine Market Forecast
10.4.3 UK Personalized Cancer Medicine Market Forecast
10.4.4 Italy Personalized Cancer Medicine Market Forecast
10.4.5 Russia Personalized Cancer Medicine Market Forecast
10.5 Middle East & Africa Personalized Cancer Medicine Forecast by Region (2025-2030)
10.5.1 Egypt Personalized Cancer Medicine Market Forecast
10.5.2 South Africa Personalized Cancer Medicine Market Forecast
10.5.3 Israel Personalized Cancer Medicine Market Forecast
10.5.4 Turkey Personalized Cancer Medicine Market Forecast
10.5.5 GCC Countries Personalized Cancer Medicine Market Forecast
10.6 Global Personalized Cancer Medicine Forecast by Method (2025-2030)
10.7 Global Personalized Cancer Medicine Forecast by Application (2025-2030)
11 Key Players Analysis
11.1 AbbVie
11.1.1 AbbVie Company Information
11.1.2 AbbVie Personalized Cancer Medicine Product Offered
11.1.3 AbbVie Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 AbbVie Main Business Overview
11.1.5 AbbVie Latest Developments
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Information
11.2.2 Johnson & Johnson Personalized Cancer Medicine Product Offered
11.2.3 Johnson & Johnson Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Johnson & Johnson Main Business Overview
11.2.5 Johnson & Johnson Latest Developments
11.3 Novartis
11.3.1 Novartis Company Information
11.3.2 Novartis Personalized Cancer Medicine Product Offered
11.3.3 Novartis Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Novartis Main Business Overview
11.3.5 Novartis Latest Developments
11.4 Gilead Sciences
11.4.1 Gilead Sciences Company Information
11.4.2 Gilead Sciences Personalized Cancer Medicine Product Offered
11.4.3 Gilead Sciences Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Gilead Sciences Main Business Overview
11.4.5 Gilead Sciences Latest Developments
11.5 Roche
11.5.1 Roche Company Information
11.5.2 Roche Personalized Cancer Medicine Product Offered
11.5.3 Roche Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Roche Main Business Overview
11.5.5 Roche Latest Developments
11.6 Bristol-Myers Squibb
11.6.1 Bristol-Myers Squibb Company Information
11.6.2 Bristol-Myers Squibb Personalized Cancer Medicine Product Offered
11.6.3 Bristol-Myers Squibb Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Bristol-Myers Squibb Main Business Overview
11.6.5 Bristol-Myers Squibb Latest Developments
11.7 Amgen
11.7.1 Amgen Company Information
11.7.2 Amgen Personalized Cancer Medicine Product Offered
11.7.3 Amgen Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Amgen Main Business Overview
11.7.5 Amgen Latest Developments
11.8 AstraZeneca
11.8.1 AstraZeneca Company Information
11.8.2 AstraZeneca Personalized Cancer Medicine Product Offered
11.8.3 AstraZeneca Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 AstraZeneca Main Business Overview
11.8.5 AstraZeneca Latest Developments
11.9 Merck & Co
11.9.1 Merck & Co Company Information
11.9.2 Merck & Co Personalized Cancer Medicine Product Offered
11.9.3 Merck & Co Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Merck & Co Main Business Overview
11.9.5 Merck & Co Latest Developments
11.10 Takeda
11.10.1 Takeda Company Information
11.10.2 Takeda Personalized Cancer Medicine Product Offered
11.10.3 Takeda Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Takeda Main Business Overview
11.10.5 Takeda Latest Developments
11.11 Merck KGaA
11.11.1 Merck KGaA Company Information
11.11.2 Merck KGaA Personalized Cancer Medicine Product Offered
11.11.3 Merck KGaA Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Merck KGaA Main Business Overview
11.11.5 Merck KGaA Latest Developments
11.12 Seagen
11.12.1 Seagen Company Information
11.12.2 Seagen Personalized Cancer Medicine Product Offered
11.12.3 Seagen Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Seagen Main Business Overview
11.12.5 Seagen Latest Developments
11.13 Eli Lilly
11.13.1 Eli Lilly Company Information
11.13.2 Eli Lilly Personalized Cancer Medicine Product Offered
11.13.3 Eli Lilly Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Eli Lilly Main Business Overview
11.13.5 Eli Lilly Latest Developments
11.14 Ono Pharmaceutical
11.14.1 Ono Pharmaceutical Company Information
11.14.2 Ono Pharmaceutical Personalized Cancer Medicine Product Offered
11.14.3 Ono Pharmaceutical Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Ono Pharmaceutical Main Business Overview
11.14.5 Ono Pharmaceutical Latest Developments
11.15 Pfizer
11.15.1 Pfizer Company Information
11.15.2 Pfizer Personalized Cancer Medicine Product Offered
11.15.3 Pfizer Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 Pfizer Main Business Overview
11.15.5 Pfizer Latest Developments
11.16 GSK
11.16.1 GSK Company Information
11.16.2 GSK Personalized Cancer Medicine Product Offered
11.16.3 GSK Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2019-2024)
11.16.4 GSK Main Business Overview
11.16.5 GSK Latest Developments
11.17 Exelixis
11.17.1 Exelixis Company Information
11.17.2 Exelixis Personalized Cancer Medicine Product Offered
11.17.3 Exelixis Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2019-2024)
11.17.4 Exelixis Main Business Overview
11.17.5 Exelixis Latest Developments
11.18 Regeneron
11.18.1 Regeneron Company Information
11.18.2 Regeneron Personalized Cancer Medicine Product Offered
11.18.3 Regeneron Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2019-2024)
11.18.4 Regeneron Main Business Overview
11.18.5 Regeneron Latest Developments
11.19 Innovent
11.19.1 Innovent Company Information
11.19.2 Innovent Personalized Cancer Medicine Product Offered
11.19.3 Innovent Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2019-2024)
11.19.4 Innovent Main Business Overview
11.19.5 Innovent Latest Developments
11.20 Hengrui Medicine
11.20.1 Hengrui Medicine Company Information
11.20.2 Hengrui Medicine Personalized Cancer Medicine Product Offered
11.20.3 Hengrui Medicine Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2019-2024)
11.20.4 Hengrui Medicine Main Business Overview
11.20.5 Hengrui Medicine Latest Developments
12 Research Findings and Conclusion

List of Tables
Table 1. Personalized Cancer Medicine Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Cancer Immunotherapy
Table 3. Major Players of Targeted Therapy
Table 4. Personalized Cancer Medicine Market Size CAGR by Method (2019 VS 2023 VS 2030) & ($ Millions)
Table 5. Global Personalized Cancer Medicine Market Size by Method (2019-2024) & ($ Millions)
Table 6. Global Personalized Cancer Medicine Market Size Market Share by Method (2019-2024)
Table 7. Personalized Cancer Medicine Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global Personalized Cancer Medicine Market Size by Application (2019-2024) & ($ Millions)
Table 9. Global Personalized Cancer Medicine Market Size Market Share by Application (2019-2024)
Table 10. Global Personalized Cancer Medicine Revenue by Players (2019-2024) & ($ Millions)
Table 11. Global Personalized Cancer Medicine Revenue Market Share by Player (2019-2024)
Table 12. Personalized Cancer Medicine Key Players Head office and Products Offered
Table 13. Personalized Cancer Medicine Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Personalized Cancer Medicine Market Size by Regions 2019-2024 & ($ Millions)
Table 17. Global Personalized Cancer Medicine Market Size Market Share by Regions (2019-2024)
Table 18. Global Personalized Cancer Medicine Revenue by Country/Region (2019-2024) & ($ millions)
Table 19. Global Personalized Cancer Medicine Revenue Market Share by Country/Region (2019-2024)
Table 20. Americas Personalized Cancer Medicine Market Size by Country (2019-2024) & ($ Millions)
Table 21. Americas Personalized Cancer Medicine Market Size Market Share by Country (2019-2024)
Table 22. Americas Personalized Cancer Medicine Market Size by Method (2019-2024) & ($ Millions)
Table 23. Americas Personalized Cancer Medicine Market Size Market Share by Method (2019-2024)
Table 24. Americas Personalized Cancer Medicine Market Size by Application (2019-2024) & ($ Millions)
Table 25. Americas Personalized Cancer Medicine Market Size Market Share by Application (2019-2024)
Table 26. APAC Personalized Cancer Medicine Market Size by Region (2019-2024) & ($ Millions)
Table 27. APAC Personalized Cancer Medicine Market Size Market Share by Region (2019-2024)
Table 28. APAC Personalized Cancer Medicine Market Size by Method (2019-2024) & ($ Millions)
Table 29. APAC Personalized Cancer Medicine Market Size Market Share by Method (2019-2024)
Table 30. APAC Personalized Cancer Medicine Market Size by Application (2019-2024) & ($ Millions)
Table 31. APAC Personalized Cancer Medicine Market Size Market Share by Application (2019-2024)
Table 32. Europe Personalized Cancer Medicine Market Size by Country (2019-2024) & ($ Millions)
Table 33. Europe Personalized Cancer Medicine Market Size Market Share by Country (2019-2024)
Table 34. Europe Personalized Cancer Medicine Market Size by Method (2019-2024) & ($ Millions)
Table 35. Europe Personalized Cancer Medicine Market Size Market Share by Method (2019-2024)
Table 36. Europe Personalized Cancer Medicine Market Size by Application (2019-2024) & ($ Millions)
Table 37. Europe Personalized Cancer Medicine Market Size Market Share by Application (2019-2024)
Table 38. Middle East & Africa Personalized Cancer Medicine Market Size by Region (2019-2024) & ($ Millions)
Table 39. Middle East & Africa Personalized Cancer Medicine Market Size Market Share by Region (2019-2024)
Table 40. Middle East & Africa Personalized Cancer Medicine Market Size by Method (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Personalized Cancer Medicine Market Size Market Share by Method (2019-2024)
Table 42. Middle East & Africa Personalized Cancer Medicine Market Size by Application (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Personalized Cancer Medicine Market Size Market Share by Application (2019-2024)
Table 44. Key Market Drivers & Growth Opportunities of Personalized Cancer Medicine
Table 45. Key Market Challenges & Risks of Personalized Cancer Medicine
Table 46. Key Industry Trends of Personalized Cancer Medicine
Table 47. Global Personalized Cancer Medicine Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 48. Global Personalized Cancer Medicine Market Size Market Share Forecast by Regions (2025-2030)
Table 49. Global Personalized Cancer Medicine Market Size Forecast by Method (2025-2030) & ($ Millions)
Table 50. Global Personalized Cancer Medicine Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 51. AbbVie Details, Company Type, Personalized Cancer Medicine Area Served and Its Competitors
Table 52. AbbVie Personalized Cancer Medicine Product Offered
Table 53. AbbVie Personalized Cancer Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 54. AbbVie Main Business
Table 55. AbbVie Latest Developments
Table 56. Johnson & Johnson Details, Company Type, Personalized Cancer Medicine Area Served and Its Competitors
Table 57. Johnson & Johnson Personalized Cancer Medicine Product Offered
Table 58. Johnson & Johnson Main Business
Table 59. Johnson & Johnson Personalized Cancer Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 60. Johnson & Johnson Latest Developments
Table 61. Novartis Details, Company Type, Personalized Cancer Medicine Area Served and Its Competitors
Table 62. Novartis Personalized Cancer Medicine Product Offered
Table 63. Novartis Main Business
Table 64. Novartis Personalized Cancer Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 65. Novartis Latest Developments
Table 66. Gilead Sciences Details, Company Type, Personalized Cancer Medicine Area Served and Its Competitors
Table 67. Gilead Sciences Personalized Cancer Medicine Product Offered
Table 68. Gilead Sciences Main Business
Table 69. Gilead Sciences Personalized Cancer Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 70. Gilead Sciences Latest Developments
Table 71. Roche Details, Company Type, Personalized Cancer Medicine Area Served and Its Competitors
Table 72. Roche Personalized Cancer Medicine Product Offered
Table 73. Roche Main Business
Table 74. Roche Personalized Cancer Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 75. Roche Latest Developments
Table 76. Bristol-Myers Squibb Details, Company Type, Personalized Cancer Medicine Area Served and Its Competitors
Table 77. Bristol-Myers Squibb Personalized Cancer Medicine Product Offered
Table 78. Bristol-Myers Squibb Main Business
Table 79. Bristol-Myers Squibb Personalized Cancer Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 80. Bristol-Myers Squibb Latest Developments
Table 81. Amgen Details, Company Type, Personalized Cancer Medicine Area Served and Its Competitors
Table 82. Amgen Personalized Cancer Medicine Product Offered
Table 83. Amgen Main Business
Table 84. Amgen Personalized Cancer Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 85. Amgen Latest Developments
Table 86. AstraZeneca Details, Company Type, Personalized Cancer Medicine Area Served and Its Competitors
Table 87. AstraZeneca Personalized Cancer Medicine Product Offered
Table 88. AstraZeneca Main Business
Table 89. AstraZeneca Personalized Cancer Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 90. AstraZeneca Latest Developments
Table 91. Merck & Co Details, Company Type, Personalized Cancer Medicine Area Served and Its Competitors
Table 92. Merck & Co Personalized Cancer Medicine Product Offered
Table 93. Merck & Co Main Business
Table 94. Merck & Co Personalized Cancer Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 95. Merck & Co Latest Developments
Table 96. Takeda Details, Company Type, Personalized Cancer Medicine Area Served and Its Competitors
Table 97. Takeda Personalized Cancer Medicine Product Offered
Table 98. Takeda Main Business
Table 99. Takeda Personalized Cancer Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 100. Takeda Latest Developments
Table 101. Merck KGaA Details, Company Type, Personalized Cancer Medicine Area Served and Its Competitors
Table 102. Merck KGaA Personalized Cancer Medicine Product Offered
Table 103. Merck KGaA Personalized Cancer Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 104. Merck KGaA Main Business
Table 105. Merck KGaA Latest Developments
Table 106. Seagen Details, Company Type, Personalized Cancer Medicine Area Served and Its Competitors
Table 107. Seagen Personalized Cancer Medicine Product Offered
Table 108. Seagen Main Business
Table 109. Seagen Personalized Cancer Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 110. Seagen Latest Developments
Table 111. Eli Lilly Details, Company Type, Personalized Cancer Medicine Area Served and Its Competitors
Table 112. Eli Lilly Personalized Cancer Medicine Product Offered
Table 113. Eli Lilly Main Business
Table 114. Eli Lilly Personalized Cancer Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 115. Eli Lilly Latest Developments
Table 116. Ono Pharmaceutical Details, Company Type, Personalized Cancer Medicine Area Served and Its Competitors
Table 117. Ono Pharmaceutical Personalized Cancer Medicine Product Offered
Table 118. Ono Pharmaceutical Main Business
Table 119. Ono Pharmaceutical Personalized Cancer Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 120. Ono Pharmaceutical Latest Developments
Table 121. Pfizer Details, Company Type, Personalized Cancer Medicine Area Served and Its Competitors
Table 122. Pfizer Personalized Cancer Medicine Product Offered
Table 123. Pfizer Main Business
Table 124. Pfizer Personalized Cancer Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 125. Pfizer Latest Developments
Table 126. GSK Details, Company Type, Personalized Cancer Medicine Area Served and Its Competitors
Table 127. GSK Personalized Cancer Medicine Product Offered
Table 128. GSK Main Business
Table 129. GSK Personalized Cancer Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 130. GSK Latest Developments
Table 131. Exelixis Details, Company Type, Personalized Cancer Medicine Area Served and Its Competitors
Table 132. Exelixis Personalized Cancer Medicine Product Offered
Table 133. Exelixis Main Business
Table 134. Exelixis Personalized Cancer Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 135. Exelixis Latest Developments
Table 136. Regeneron Details, Company Type, Personalized Cancer Medicine Area Served and Its Competitors
Table 137. Regeneron Personalized Cancer Medicine Product Offered
Table 138. Regeneron Main Business
Table 139. Regeneron Personalized Cancer Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 140. Regeneron Latest Developments
Table 141. Innovent Details, Company Type, Personalized Cancer Medicine Area Served and Its Competitors
Table 142. Innovent Personalized Cancer Medicine Product Offered
Table 143. Innovent Main Business
Table 144. Innovent Personalized Cancer Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 145. Innovent Latest Developments
Table 146. Hengrui Medicine Details, Company Type, Personalized Cancer Medicine Area Served and Its Competitors
Table 147. Hengrui Medicine Personalized Cancer Medicine Product Offered
Table 148. Hengrui Medicine Main Business
Table 149. Hengrui Medicine Personalized Cancer Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 150. Hengrui Medicine Latest Developments

Related Reports

One individual can access, store, display, or archive the report in Excel format but cannot print, copy, or share it. Use is confidential and internal only. Read More

One individual can access, store, display, or archive the report in PDF format but cannot print, copy, or share it. Use is confidential and internal only. Read More

Up to 10 employees in one region can store, display, duplicate, and archive the report for internal use. Use is confidential and printable. Read More

All employees globally can access, print, copy, and cite data externally (with attribution to Bonafide Research). Read More

Buy Now

Safe and Secure SSL Encrypted

Quick Contacts

Want to customize this report?

We offer 10% Free Customization at the time of purchase

Get Free Customization

I'm Available

Nikita Jabrela

Business Development Manager

Interested to schedule a FACE-TO-FACE meeting? Schedule a Call

Trusted Partners

Budget constraints? Get in touch with us for special pricing

Request Discount

Order Detail

Order Placed (21 March, 2025)
Notify To Team (21 March, 2025)
Report updation (22 March, 2025)
Report Quality Check (22 March, 2025)
Report Dispatch (23 March, 2025)

Email
Hard Copy

Research Methodology

An Adaptive Approach to Modern-day Research Needs

Get Methodology

Searching...

Global Personalized Cancer Medicine Market Growth (Status and Outlook) 2024-2030

2024